tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Butler, 252 are a BUY (94.03%), 14 are a HOLD (5.22%), 2 are a SELL (0.75%).
Analyst Jason Butler, currently employed at JMP, carries an average stock price target met ratio of 36.96% that have a potential upside of 60.82% achieved within 219 days.
Jason Butler’s has documented 505 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on CYTK, Cytokinetics at 25-Feb-2026.
Analyst best performing recommendations are on TRVN (TREVENA).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS) at 2/24/2021. The price target of $48 was fulfilled within 1 day with a profit of $3.45 (6.71%) receiving and performance score of 67.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Oct-2023
$34
$11.84 (53.43%)
$31
8 days ago
(04-Mar-2026)
8/15 (53.33%)
$11.5 (51.11%)
113
Buy Since 26-Jun-2025
$30
$7.84 (35.38%)
$31
14 days ago
(26-Feb-2026)
0/6 (0%)
$5.03 (20.14%)
Buy Since 07-Aug-2015
$37
$14.84 (66.97%)
$35
14 days ago
(26-Feb-2026)
7/16 (43.75%)
$12.03 (48.18%)
671
Hold Since 03-Nov-2022
$24
$1.84 (8.30%)
$25
14 days ago
(26-Feb-2026)
19/22 (86.36%)
$-0.97 (-3.88%)
112
Hold Since 08-Oct-2025
$35
$12.84 (57.94%)
$29
17 days ago
(23-Feb-2026)
1/3 (33.33%)
$11.01 (45.89%)
35
Which stock is Jason Butler is most bullish on?
Which stock is Jason Butler is most reserved on?
What Year was the first public recommendation made by Jason Butler?
